Microdosing GLP-1 for long-term weight management

Introduction: The part after the weight comes off

Losing weight is one challenge; maintaining the change is another. After weight loss, the body undergoes hormonal and metabolic changes that can make weight regain more likely. This is a documented physiological reality, not a matter of willpower, and it's central to why weight management is often discussed as a long-term effort. This is an educational overview. It isn't medical advice or a promise of a specific result.

What tends to happen after stopping GLP-1 medications

Research has found that many people regain a substantial portion of lost weight after stopping GLP-1 medications. The general explanation is that these medications address the underlying biology of appetite and weight regulation rather than permanently changing it, so when the medication stops, the biological drivers can reassert themselves. It's often compared to other chronic conditions where stopping treatment allows the underlying issue to return. Whether and how this applies to you is individual and best discussed with a provider.

Why a lower-dose approach is discussed for the long term

If a medication may be used over a long period, tolerability, cost, and sustainability all become relevant. That's part of why a lower-dose, clinician-guided approach is discussed for long-term use: it emphasizes finding a dose that a person can reasonably sustain. Whether long-term use, and at what dose, is appropriate is a clinical decision.

Building habits alongside medication

Medication is most useful as part of a broader approach. Habits that commonly support long-term weight management include resistance training to help preserve muscle, adequate protein intake, consistent sleep, and stress management. These are general lifestyle principles, not outcomes attributable to any medication.

The maintenance phase

As goals are reached, a provider may adjust the dose over time. Some people continue at a low maintenance dose; others taper off while maintaining habits built during treatment. Both are reasonable paths, and which fits you is a decision made with your provider.

A long-term partnership

Luvo's Microdosing Program is clinician-guided and designed to support ongoing care, with a provider adjusting treatment as your needs change. Its compounded medications are not FDA-approved. Explore Luvo's Microdosing Program to learn more.